Aug 21 (Reuters) – Scholar Rock said on Friday it withdrew its European application for the experimental spinal muscular atrophy drug and plans to resubmit it with a different manufacturing site after
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Jessica Korda welcomes baby girl: 'No longer outnumbered'
Jessica Korda is proud to be a "girl mom." The LPGA golfer and husband Johnny…
Medvedev rallies into Shanghai third round, Auger-Aliassime and Jodar advance
VIDEO SHOWS: HIGHLIGHTS OF THE ATP 1000 SHANGHAI MASTERS COMPLETE SCRIPT TO FOLLOW SHOWS: SHANGHAI,…
INDIA'S MISSION TO GENEVA ON DELHI PROTESTS: OHCHR’S CONCERNS ARE MISPLACED, CONSTITUTE UNWARRANTED INTERFERENCE IN…
